Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam E Mullick

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
The Journal of Clinical Investigation|July 12, 2016
ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptorsPhilip L S M Gordts, Ryan Nock, Ni-Huiping Son, et al.
Kidney International|March 21, 2016
Antagonism of scavenger receptor CD36 by 5A peptide prevents chronic kidney disease progression in mice independent of blood pressure regulationAna Carolina P Souza, Alexander V Bocharov, Irina N Baranova, et al.
JCI Insight|December 6, 2022
LRP1 protects against excessive superior mesenteric artery remodeling by modulating angiotensin II-mediated signalingJackie M Zhang, Dianaly T Au, Hisashi Sawada, et al.
International Journal of Molecular Sciences|March 10, 2022
Antisense Therapy Attenuates Phospholamban p.(Arg14del) Cardiomyopathy in Mice and Reverses Protein AggregationTim R Eijgenraam, Nienke M Stege, Vivian Oliveira Nunes Teixeira, et al.
Signal Transduction and Targeted Therapy|May 27, 2026
Phosphoproteomics distinguishes disease-specific mechanisms for human phospholamban cardiomyopathy reversible by RNA therapyFrederik E Deiman, Nils Bömer, Pia Davidsson, et al.
The Journal of Clinical Investigation|July 27, 2018
Endothelial cell CD36 optimizes tissue fatty acid uptakeNi-Huiping Son, Debapriya Basu, Dmitri Samovski, et al.
Nucleic Acids Research|May 12, 2019
Conjugation of hydrophobic moieties enhances potency of antisense oligonucleotides in the muscle of rodents and non-human primatesMichael E Østergaard, Michaela Jackson, Audrey Low, et al.
Research Square|July 25, 2025
Elevated apolipoprotein C3 heightens atherosclerosis risk by mediating arterial accumulation of free cholesterol and local inflammation in diabetesJenny E Kanter, Cheng-Chieh Hsu, Farah Kramer, et al.
Circulation|August 19, 2024
Antisense Oligonucleotide Therapy for CalmodulinopathyRaul H Bortolin, Farina Nawar, Chaehyoung Park, et al.
Nature Communications|August 31, 2021
Phospholamban antisense oligonucleotides improve cardiac function in murine cardiomyopathyNiels Grote Beverborg, Daniela Später, Ralph Knöll, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
The Journal of Clinical Investigation|July 12, 2016
ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptorsPhilip L S M Gordts, Ryan Nock, Ni-Huiping Son, et al.
Kidney International|March 21, 2016
Antagonism of scavenger receptor CD36 by 5A peptide prevents chronic kidney disease progression in mice independent of blood pressure regulationAna Carolina P Souza, Alexander V Bocharov, Irina N Baranova, et al.
JCI Insight|December 6, 2022
LRP1 protects against excessive superior mesenteric artery remodeling by modulating angiotensin II-mediated signalingJackie M Zhang, Dianaly T Au, Hisashi Sawada, et al.
International Journal of Molecular Sciences|March 10, 2022
Antisense Therapy Attenuates Phospholamban p.(Arg14del) Cardiomyopathy in Mice and Reverses Protein AggregationTim R Eijgenraam, Nienke M Stege, Vivian Oliveira Nunes Teixeira, et al.
Signal Transduction and Targeted Therapy|May 27, 2026
Phosphoproteomics distinguishes disease-specific mechanisms for human phospholamban cardiomyopathy reversible by RNA therapyFrederik E Deiman, Nils Bömer, Pia Davidsson, et al.
The Journal of Clinical Investigation|July 27, 2018
Endothelial cell CD36 optimizes tissue fatty acid uptakeNi-Huiping Son, Debapriya Basu, Dmitri Samovski, et al.
Nucleic Acids Research|May 12, 2019
Conjugation of hydrophobic moieties enhances potency of antisense oligonucleotides in the muscle of rodents and non-human primatesMichael E Østergaard, Michaela Jackson, Audrey Low, et al.
Research Square|July 25, 2025
Elevated apolipoprotein C3 heightens atherosclerosis risk by mediating arterial accumulation of free cholesterol and local inflammation in diabetesJenny E Kanter, Cheng-Chieh Hsu, Farah Kramer, et al.
Circulation|August 19, 2024
Antisense Oligonucleotide Therapy for CalmodulinopathyRaul H Bortolin, Farina Nawar, Chaehyoung Park, et al.
Nature Communications|August 31, 2021
Phospholamban antisense oligonucleotides improve cardiac function in murine cardiomyopathyNiels Grote Beverborg, Daniela Später, Ralph Knöll, et al.
Pageof 9